|Articles|November 2, 2014

Pharmaceutical Technology

  • Pharmaceutical Technology-11-02-2014
  • Volume 38
  • Issue 11

Steritest Symbio Pumps Increase Productivity

EMD Millipore's Steritest Symbio Pumps are designed to create more reliable sterility testing in laminar flow hoods, isolators, and clean rooms.

EMD Millipore’s Steritest Symbio Pumps are designed to create more reliable sterility testing in laminar flow hoods, isolators, and clean rooms. Designed to address pharmaceutical testing requirements, the ergonomic pumps feature a compact housing design for easier access in laminar flow hoods, more compatibility with vertical and horizontal air flows, increased working space, an increased loading capacity in isolators, a drain tray designed to minimize splashing under the canister base, and adjustable positioning of the bottle holder.

The gas decontamination-resistant pump head allows quick introduction of filtration units, and the automatic closure provides repeatable tubing placement. The pumps are equipped with a timer function that allows small volumes to be accurately sampled, and the test methods library stores up to 250 filtration protocols ensuring reproducibility and efficiency.

EMD Milliporewww.emdmillipore.com

Articles in this issue


Related to this article

Are Your Supplier Selection and Oversight Processes Robust Enough?
Despite best efforts to ensure a contract organization is following GMPs, a warning letter is issued by the FDA. Susan J. Schniepp, distinguished fellow at Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, provide advice for create a robust supplier selection and oversight system.
white pill capsule isolated on white background | Image Credit: ©F16-ISO100 -stock.adobe.com
PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s hydroxypropyl methylcellulose (HPMC) capsule, which was previewed at CPHI Milan 2026 in October.
Transitioning mRNA from R&D to GMP
Marco Pupo, PhD, innovation and development coordinator at Anemocyte, discusses the R&D-to-GMP transition and the changing shape of mRNA manufacturing facilities.